Biotechnology
Healthcare
Medical

GlaxoSmithKline

$41.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.10%) Today
$0.00 (0.00%) As of 4:31 PM EDT after-hours

Why Robinhood?

You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!

About GSK

GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees
95,490
Headquarters
Brentford, Greater London
Founded
1999
Market Cap
101.84B
Price-Earnings Ratio
19.90
Dividend Yield
5.40
Average Volume
2.79M
High Today
$41.30
Low Today
$41.08
Open Price
$41.26
Volume
1.76M
52 Week High
$42.32
52 Week Low
$36.41

Collections

Biotechnology
Healthcare
Medical
Pharmaceutical
Female CEOs
Health
Research And Development
Health And Wellness

GSK News

MarketWatchJul 15

GlaxoSmithKline: Phase 3 study of Zejula met goals

21
ReutersJul 14

GSK in talks to name HSBC's Symonds as its next chairman: Bloomberg

7
MarketWatchJul 11

EU OKs Glaxo buy of Pfizer unit, with conditions

537

GSK Earnings

$0.34
$0.52
$0.70
$0.88
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 24

Popular Stocks

More GSK News

ReutersJul 10

GSK's Dovato suppresses AIDS virus at same levels of three-drug regimen

109
ReutersJul 10

UPDATE 1-UK Stocks - Factors to watch on July 10

13
MarketWatchJul 10

GlaxoSmithKline, Pfizer HIV drug in positive trial

652
Financial PostJul 10

GSK's Dovato meets primary goal in late-stage HIV study

11
ReutersJul 8

U.S. seeks extradition of Chinese researcher in drug secrets theft

81
ReutersJul 2

GSK-Pfizer joint venture gets conditional approval from South Africa's competition regulator

81
Seeking AlphaJun 20

Glaxo offers concessions to address Pfizer deal concerns

438
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.